Personalized neoantigen cancer vaccines: Why clinical benefit remains inconsistent

Critical Reviews in Oncology/Hematology 2026

View at publisher
Authors: Shishir Singh, Monisha Banerjee, Atar Singh Kushwah
DOI: 10.1016/j.critrevonc.2026.105336
Cited by: 5
References: 69

Fields of Study & Subjects

Immunotherapy and Immune Responses vaccines and immunoinformatics approaches Cancer Immunotherapy and Biomarkers

Publication details

Journal / source
Critical Reviews in Oncology/Hematology
Publisher
Elsevier BV
Volume
223
Pages
105336–105336
Publication date
12 April 2026
Language
EN